Clearside Biomedical (NASDAQ:CLSD) Given “Market Outperform” Rating at JMP Securities
JMP Securities reiterated their market outperform rating on shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) in a research note issued to investors on Friday,Benzinga reports. The firm currently has a $5.00 price target on the stock. A number of other research firms have also recently commented on CLSD. Needham & Company LLC decreased their […]
JMP Securities reiterated their market outperform rating on shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) in a research note issued to investors on Friday,Benzinga reports. The firm currently has a $5.00 price target on the stock. A number of other research firms have also recently commented on CLSD. Needham & Company LLC decreased their […]
